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Synthetic nanostructures based on self-assembling systems that aim to mimic natural extracellular
matrix are now being used as substrates in tissue engineering applications. Peptides are excellent
starting materials for the self-assembly process as they can be readily synthesised both chemically and
biologically. P11-4 is an 11 amino acid peptide that undergoes triggered self-assembly to form a self-
supporting hydrogel. It exists as unimers of random coil conformations in water above pH 7.5 but at low
pH adopts an antiparallel b-sheet conformation. It also self-assembles under physiological conditions in
a concentration-dependent manner. Here we describe an unimer P11-4 production system and the use of
a simple site-directed mutagenesis approach to generate a series of other P11-family peptide expression
vectors. We have developed an efﬁcient puriﬁcation strategy for these peptide biomaterials using
a simple procedure involving chemical cleavage with cyanogen bromide then repeated ﬁltration, lyo-
philisation and wash steps. We report peptide-fusion protein yields of ca. 4.64 g/L and we believe the
highest reported recovery of a recombinant self-assembling peptide at 203 mg/L of pure recombinant
P11-4. This peptide forms a self-supporting hydrogel under physiological conditions with essentially
identical physico-chemical properties to the chemically synthesised peptide. Critically it also displays
excellent cytocompatibility when tested with primary human dermal ﬁbroblasts. This study demon-
strates that high levels of a series of recombinant self-assembling peptides can be puriﬁed using a simple
process for applications as scaffolds in tissue engineering.
 2010 Elsevier Ltd. Open access under CC BY license.1. Introduction
Over the past two decades self-assembling peptides have
emerged as potential candidates for the development of safe
nanostructured scaffolds in the ﬁeld of tissue engineering [1e10].
Oligomeric peptides have been rationally designed to spontane-
ously self-assemble into hierarchical structures in solution, in
response to speciﬁc physico-chemical environmental triggers,
thus providing a new generation of well-deﬁned biopolymers
[11e14]. Under controlled conditions self-assembling peptides of
the P11-family undergo one-dimensional self-assembly, forming
single molecule thick, micrometer-long b-sheet nanotapes.
Further assembly results in the nanotapes stacking in pairs to
form ribbons which further assemble to form ﬁbrils, then pairs of
ﬁbrils can entwine to form ﬁbres. Over twenty systematically
varied P11 peptides have been designed by Aggeli and colleaguesCellular Biology, Faculty of
el.: þ44 (0) 113 3432595.
cPherson).
 license.to self-assemble using various physico-chemical triggers and give
rise to self-supporting isotropic or liquid crystalline hydrogels at
peptide concentrations of 10e30 mg/ml [12]. These peptides vary
in terms of overall charge, hydrophobicity and type of polar amino
acids resulting in nanostructured ﬁbrillar peptide networks with
different solvent afﬁnity and dissolution rate.
As an example, self-assembling peptide P11-4 (QQRFEWEFEQQ)
(Fig. 1) was designed to form ﬁbrils at low pH and to be monomeric
in solution at higher pH. The incorporation of glutamic acid resi-
dues at position 5, 7 and 9 means there is no charge on the g-
carboxyl groups at pH 2. However a positive net charge of one
exists on the arginine. This allows antiparallel b-sheet assembly by
Coulombic interactions. The terminal glutamine residues
contribute to hydrophobic interactions as well as complementary
hydrogen bonding, whilst the aromatic residues phenylalanine,
tryptophan and phenylalanine at positions 4, 6 and 8 respectively,
promote pep interactions of the aromatic rings and aid in the
association of tapes into ribbons in aqueous conditions. By contrast
at higher pH, all three glutamates carry a negative charge and
electrostatic repulsion will therefore prevent efﬁcient b-sheet
Fig. 1. A schematic representation of rP11-4 peptide (QQRFEWEFEQQ) adopting an antiparallel b-sheet conformation.
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140 mM has been shown to induce a ﬂuid to gel transition at
a critical concentration of 6.3 mM at pH 6. The sodium ions will
screen the electrostatic forces between the net negatively charged
P11-4 ﬁbrils [12].
Most self-assembling peptides described in the literature have
been produced using solid-state synthesis. This is efﬁcient for small
scale production and testing, but modest scale-up can be expensive
while industrial scale production can be very challenging. It can also
be difﬁcult to produce peptides of lengths over 35 residues in
acceptable yields and there are environmental considerations in
disposal of chemical waste. An alternative approach is to produce
peptides biosynthetically using recombinant microorganisms [15],
which presents different challenges. Speciﬁcally, such small
peptides are often difﬁcult to express in bacterial cells due to their
propensity to self-associate, mediate toxicity or be rapidly degraded
byproteases [16]. Such issues canbe addressed by fusing thepeptide
to a larger carrier protein to improve intracellular stability [17] and
provide amechanism for initial puriﬁcation. A further problem then
arises in removing the fusion partner, following chemical or enzy-
matic cleavage, to leave pure peptide monomer in solution.
We have previously reported on the use of a pET31-based
expression system to produce trimers of P11-4 with subsequent
cyanogen bromide cleavage and reverse phase HPLC [18]. This
study provided the highest yields of recombinant self-assembling
peptide-fusion protein (2.5 g/L) using an auto-induction process
[19] and of pure peptide (90 mg/L). However, one issue with this
trimer approach was the production of peptide species with a C-
terminal homoserine lactone moiety due to cyanogen bromide
(CNBr) cleavage. Similar studies have been reported by Middelberg
and co-workers on recombinant production of a related peptide
P11-2 (QQRFQWQFEQQ) using a pET31 system with intervening
cysteines and cleavage of peptides by 1-cyano-4-dimethylamino-
pyridinium tetraﬂuoroborate. In this case protein expression used
IPTG induction and therefore gave relatively low levels of protein
with puriﬁcation of 2.63 mg peptide/L culture after reverse phase
(rp)HPLC which represents a 42% yield of peptide [17]. Subse-
quently they developed a chromatography-free puriﬁcation system
based on thioredoxin as the fusion partner and with tobacco etch
virus protease release of the peptide in heat treated whole cell
homogenates. Ethanol precipitation in the presence of 250mMNaCl
was used to precipitate other material leaving peptide in solution.
They recovered 13 mg peptide/L culture, although they did use
a rpHPLC step to perform buffer exchange of peptide samples for
characterisation [20].The purpose of this study was to improve upon a recombinant
expression and puriﬁcation strategy [18] for self-assembling
peptide production, to simplify the puriﬁcation, to demonstrate the
general applicability of the approach for peptide biomaterial
production and to perform more detailed characterisation (hydro-
gel formation, CD, FTIR, TEM) and cytocompatibility studies on one
of these recombinant peptides, P11-4 (rP11-4). To ensure production
of homogenous native peptide without any associated homoserine
lactone species derived from CNBr cleavage, we used an unimer
fusion construct with the ketosteroid isomerase separated from
a single P11-4 peptide encoding sequence by a methionine residue.
We then used this recombinant vector as a template to generate
a series of further P11-family peptide constructs by using a site-
directed mutagenesis strategy. To simplify the downstream
processing we used cell lysis and fractionation to give the insoluble
inclusion body-based pellet, with subsequent cleavage of the
peptide from the fusion protein, and non-chromatographic puriﬁ-
cation of peptide in water. All the puriﬁed peptides were analysed
by SDS-PAGE and mass spectrometry. Puriﬁed rP11-4 was then used
directly in further peptide characterisation assays and importantly
the cytocompatibility of rP11-4 hydrogel was also tested using
primary human dermal ﬁbroblasts.
2. Materials and methods
2.1. Bacterial strains, plasmids, and cell culture medium
Escherichia coli XL1 Blue (Stratagene, La Jolla, CA.) was used for routine cloning
and BL21 Star (DE3) (Invitrogen, Carlsbad, CA.) was used as the expression strain.
The expression vector pET31bþ was from Novagen, UK.
The growth medium Luria Burtani (LB), and LB agar were prepared according to
[21]. Auto-induction mediumwas prepared as described by [19]. The components of
various auto-induction media are given in Table 1. Carbenicillin (Fisher Scientiﬁc
Ltd., UK) was added to medium to a ﬁnal concentration of 100 mg/ml.
2.2. Generation of recombinant E. coli strains
The design of rP11-4 encoding DNA and cloning into pET31bþ has previously
been described [18]. Site-directed mutagenesis using a Quikchange protocol was
used to introduce two stop codons (bold) before the sequence encoding the C-
terminal hexa-histidine tag in pET31b-KSI-rP11-4(1)-HIS (Fig. 2; [18]) using the
following primers.
F: 50-CGAATGGGAATTTGAGCAACAGTAATAGCTCGAGCACCACCACCACCAC-30;
R: 50-GTGGTGGTGGTGGTGCTCGAGCTATTACTGTTGCTCAAATTCCCATTCG-30 .
A 50 ml reaction volume comprising 1 ml pET31b-KSI-rP11-4(1)-HIS (10 ng), 1.5 ml
(10 pmol/ml) of each primer, 5 ml 2 mM dNTPs, 5 ml 10  KOD Hot Start DNA poly-
merase buffer (200 mM TriseHCl, 80 mM MgCl2, 5 mM DTT, 500 mg/ml BSA, pH 7.5),
3 ml 10 mM MgSO4, 1 ml KOD Hot Start DNA polymerase (1 U) and 32 ml water
(molecular biology grade) was subjected to: 1 min at 94 C followed by 18 cycles of
30 s at 94 C, 30 s at 55 C and 8 min at 68 C and a ﬁnal extension step at 72 C for
Table 1
Composition of auto-induction growth media. Adapted from [19].
Growth
medium
ZY NPSC MgSO4 mM Trace metals
(1000 stock)
Lac50
Tryptone
g/L
Yeast extract
g/L
NaCl
g/L
NH4Cl
mM
Na2SO4
mM
KH2PO4
mM
Na2HPO4
mM
Glycerol Glucose a-lactose
% (v/v) % (w/v) % (w/v)
LB 10 5 10 50 5 25 25 2 0.2 0.5 0.05 0.2
8ZY4Lac 80 40 0 50 5 25 25 2 0.2 2.0 0.20 0.8
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methylated template DNA.
E. coli XL1 Blue cells were thawed on ice prior to addition of 20 ng Dpn I digest.
After 15 min on ice the sample was incubated at 42 C for 90 s and then on ice for
2 min. LB medium (1 ml) was added and the sample incubated at 37 C in an orbital
incubator (250 rpm) for 1 h. Transformed cells (50 ml) were then plated onto LB agar
with carbenicillin (100 mg/ml) and incubated at 37 C for 16 h.
Colonies were cultured in 5 ml LB medium with carbenicillin (100 mg/ml) in an
orbital incubator (250 rpm) at 37 C for 16 h. The cells were harvested by centri-
fugation at 4000 g for 10 min at 4 C and used for plasmid DNA puriﬁcation using
a QIAprep MiniPrep Kit (Qiagen Ltd., UK) according to the manufacturer’s instruc-
tions. The pET31b-KSI-rP11-4(1) DNAwas eluted in 50 ml 10 mM Tris.HCl, pH 8.5 and
stored at 20 C and the DNA sequence of the insert region conﬁrmed using T7
forward and reverse primers (ABI 3130xl capillary sequencer, DNA Sequencing
Facility, Faculty of Biological Sciences, University of Leeds).
To create further self-assembling peptide variants P11-2, P11-9, P11-13, P11-14,
P11-20 and P11-4þRGD, site-directedmutagenesis as described abovewas performed
on the pET31b-KSI-rP11-4(1) plasmid using the following primers:
KSI-rP11-2-F GCCAGATGCAGCAACGCTTTCAGTGGCAGTTTGAGCAACAGTAATAGC
KSI-rP11-2-R GCTATTACTGTTGCTCAAACTGCCACTGAAAGCGTTGCTGCATCTGGC
KSI-rP11-9-F AGCAGCCGCTTTGAATGGGAATTTGAAAGCAGCTAATAGCTCGAGCAC
CACCAC
KSI-rP11-9-R GCTGCTTTCAAATTCCCATTCAAAGCGGCTGCTCATCTGGCATGCGT G
AATATTC
KSI-rP11-13-F GAACAGGAATTTGAATGGGAATTTGAACAAGAGTAATAGCTCGAG CA
CCACCAC
KSI-rP11-13-R CTCTTGTTCAAATTCCCATTCAAATTCCTGTTCCATCTGGCATGCG TG
AATATTC
KSI-rP11-14-F AAATTTAAATGGAAATTTAAGCAACAGTAATAGCTCGAGC
KSI-rP11-14-R TTAAATTTCCATTTAAATTTTTGCTGCATCTGGCATGCG
KSI-rP11-20-F GCCAGATGCAGCAACGGCAGGAACAGGAACAGGAGCAACAGT AATA
GCTCG
KSI-rP11-20-R CGAGCTATTACTGTTGCTCCTGTTCCTGTTCCTGTTCCTGGCGT TGCT
GCATCTGGC
KSI-rP11-4þRGD-F CGCGGTGATGGCGGTGGCGGTCAGCAACGCTTCGAATGGG
KSI-rP11-4þRGD-R ACCGCCACCGCCATCACCGCGCSTCTGGCATGCGTGAATATTC
Plasmid DNAwas puriﬁed and DNA sequencing was used to conﬁrm the correct
sequences of each construct. These plasmids are similarly designated pET31b-KSI-
rP11-N(1) where N corresponds to the peptide number, so for example the construct
encoding P11-20 is designated pET31b-KSI-rP11-20(1).
2.3. Protein expression
The protocols developed by Studier [19] were followed. E. coli BL21 Star (DE3)
strains carrying expression plasmids were inoculated into 2 ml LB medium with
carbenicillin (100 mg/ml) and grown in an orbital incubator (250 rpm) at 37 C for
6 h. A 200 ml aliquot of the starter culture was used to inoculate 400 ml auto-
induction medium in a 2 L bafﬂed ﬂask with growth at 25 C in an orbital incubator
(250 rpm) for up to 72 h. Aliquots (1 ml) of cells were removed at time points
between 16 and 72 h and harvested at 13 000 rpm in a microcentrifuge. At 72 h the
remaining culture volume was harvested by centrifugation at 5000 rpm in a ﬁxed
angle rotor (Sorvall SLA3000) for 15 min.
2.4. Preparation of soluble and insoluble proteins from E. coli cultures
Cells were lysed with lysis buffer (50 mM HEPES, 25% (w/v) sucrose, 5 mM
MgCl2.6H2O and 1% (v/v) Triton X-100; pH 8). The pH of the solutionwas adjusted to
pH 8 using 6 M HCl or 6 M NaOH. Immediately prior to use, Omnicleave endonu-
clease (2 ml per 40 ml lysis buffer; Epicentre, Cambridge, UK) was added to the lysis
buffer, together with lysozyme to 1 mg/ml. The lysate was sonicated at 20 kHz using
4 bursts of 20 s with 20 s intervals then centrifuged at 22,000 g for 30 min to
separate the soluble and insoluble material. Aliquots of the supernatant (soluble
protein fraction) were reserved for analysis. The pellet containing the inclusion
bodies was washed 4e5 times in 0.1 lysis buffer by resuspension and centrifuga-
tion at 10,000 g. The resulting pellets were stored at 20 C until required.2.5. SDS-PAGE analysis
SDS-PAGE was used to separate soluble and insoluble protein fractions. An XCell
SureLockTMmini-cell system (Invitrogen, Ltd.) was used with NuPAGE 4e12% Bis-Tris
precast gels (Invitrogen, Ltd.). Samples were prepared in loading buffer (Invitrogen,
Ltd.) and heated at 95 C for 5 min prior to gel loading. Gels were electrophoresed at
a constant voltage of 190 V for 40 min then stained with SimplyBlue Safestain
(Invitrogen, Ltd.) with gentle agitation for 1 h at room temperature and washed
several times in double distilled water for 24 h. Gel images were acquired using
a Kodak Gel Logic 1500 system (Kodak Ltd.).
2.6. Protein concentration determination
Puriﬁed protein concentrations were determined by the Bradford assay (Sig-
maeAldrich, Ltd.). Peptide concentrations were determined by A280 measurement
and concentrations were calculated using the BeereLambert Law, taking the molar
extinction coefﬁcient (e) of rP11-4 as 5500 M1 cm1 [22].
2.7. Cleavage of the KSI fusion protein by cyanogen bromide (CNBr)
The KSI-r(peptide) fusion proteins were resuspended at a concentration of
10 mg/ml in 70% (w/v) formic acid. CNBr was dissolved in 70% (w/v) formic acid and
added to the protein sample to provide a 200-fold molar excess of CNBr to methi-
onine residues. The ﬂask was purgedwith N2 and incubated in the dark for 24 hwith
gentle agitation. The formic acid was then removed by rotary evaporation until
a gelatinous material formed.
2.8. Puriﬁcation of CNBr cleaved peptide
This gelatinous material was resuspended in 40 ml double distilled water and
the pH adjusted to 9 using either 5 M NaOH or 7 N ammonia inmethanol. The soluble
and insoluble fractions were separated by centrifugation at 10,000 g for 30 min. The
supernatant was ﬁltered through a 0.22 mm nitrocellulose ﬁlter that was prewashed
with water at pH 9. The ﬁltrate was lyophilised and the resulting powder resus-
pended in 10 ml double distilled water and agitated for 2 h to allow the peptide to
fully dissolve. The process of wash, ﬁltration and lyophilisation was repeated ﬁve
times. A ﬁnal lyophilisation was performed by snap freezing the samples in liquid
nitrogen which were then placed into a Heto LyoPro 6000 freeze drier until a dry
powder was formed.
2.9. Mass spectrometry
Protein and peptide samples were prepared for electrospray ionisation mass
spectrometry (ESI-MS) by dissolving dry powders in 20 ml formic acid. Samples were
submitted to theMass Spectrometry Facility, Astbury Centre, University of Leeds and
analysed by Dr. J. Ault on a Synapt HDMS (Waters UK Ltd.) mass spectrometer.
Peptide samples were subsequently sequenced by tandem mass spectrometry
(MSMS).
2.10. Formation of rP11-4 peptide hydrogel
Lyophilised rP11-4 (10 mg/ml) was reconstituted in either cell culture medium
(DMEM) or 140 mM NaCl in water (pH 7.4). In order to monomerise and reverse self-
assembly of rP11-4 the pH was increased to 9 using 0.5 M NaOH.
2.11. Transmission electron microscopy
rP11-4 was prepared at a concentration of 10mg/ml (6.3 mM) in 140mM NaCl (pH
7.4) and diluted to a peptide concentration of 100 mM in water. Glow discharged,
carbon-coated 400 hexagonal mesh copper grids were covered with 20 ml peptide
solution and allowed to adsorb for 1 min. Excess sample was removed using ﬁlter
paper and grids were negatively stained by the addition of 10 ml 2% (v/v) uranyl
acetate in water for 20 s. Excess stain was removed with ﬁlter paper and grids were
air dried prior to analysis. Images were obtained using a Jeol 1200 EX TEM operating
at 80 kV.
Fig. 2. Cloning and expression strategy for rP11-4 peptide production. P11-4 encoding oligonucleotide sequences were designed to introduce intervening methionine codons (ATG)
when annealed and cloned into the AlwNI site of pET31b. Site-directed mutagenesis was used to introduce two termination codons (TAATAG) to prevent translation of the C-
terminal methionine and hexa-histidine tag. KSI-rP11-4 fusion protein was expressed and individual rP11-4 monomers cleaved from the insoluble KSI using CNBr generating
a mixture of KSI and rP11-4. rP11-4 unimers were puriﬁed by adjusting the pH to 9, then ﬁltration, lyophilisation and wash cycles.
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Lyophilised rP11-4 hydrogel was prepared at a concentration of 10 mg/ml
(6.3 mM) in 140 mM NaCl. The pH was adjusted to 7.4 in which peptide ﬁbril asso-
ciation occurred and pH 9 in which peptide ﬁbril dissociation occurred. Samples
were left to equilibrate at 25 C for 24 h and diluted in distilled water to a ﬁnal
concentration of 100 mM prior to analysis. The pH was then reconﬁrmed. Samples
were then placed in quartz cuvettes (Hellma) with a path length of 0.1 mm. Mean
residual ellipticity readings were taken in the far UV region of the spectrum,
(190e240 nm) using a Jasco J-750 spectropolarimeter. Each spectrum was the
average of ﬁve scans with a step resolution of 0.5 nm, scan speed 50 nm min1,
response time of 1 s and a sensitivity of 50m at 20 C. Blank readings were taken for
all samples and subtracted from the data obtained from the peptide samples.
2.13. Fourier-transform infra-red spectroscopy analysis of rP11-4
rP11-4was prepared by dissolving 10mg of lyophilised peptide in 1ml of 140mM
NaCl in D2O. The pH of the solution was adjusted by addition of hydrochloric acid
(DCl) or sodium hydroxide (NaOD) to pH 7.4 and 9 respectively. Samples were mixed
thoroughly for 1 min and left to equilibrate at 25 C for 24 h. Samples (50 ml) were
then placed between CaF2 cells separated by a 50 mm Teﬂon spacer. Spectra obtained
were averages of four scans, recorded with a resolution of 4 cm1 at 25 C using
a Nicolet Magna 560 FTIR spectrometer, in which blank solvent spectra were
subtracted.
2.14. Contact cytotoxicity assay
Samples of rP11-4 hydrogel (n ¼ 3) were attached to the centre of each well of
six-well tissue culture plates using collagen type I extracted from rat tail tendons
(acid solubilised rat tail collagen and neutralised using 0.1 M NaOH). As a positive
control cyanoacrylate glue was placed into the centre of each well of a 6-well tissue
culture plate, as it has been demonstrated to produce a reproducible cytotoxic
response. As the negative control collagen type I was placed into the centre of each
well of a 6-well plate as it has been demonstrated to be biocompatible and thus not
cytotoxic. Primary human dermal ﬁbroblasts (passage 3, Cascade Biologics, Not-
tingham) were seeded at a density of 5  104 cells/ml and DMEM plus supplements
(10% (v/v) fetal calf serum, 100 U/ml penicillin, 100 mg/ml streptomycin, 10 mM
L-glutamine) added to a total of 2 ml. Plates were incubated at 37 C in 5% (v/v) CO2
in air for 48 h. The culture medium was then carefully aspirated before the wellsFig. 3. Expression of KSI-rP11-4 fusion protein. SDS-PAGE analysis of KSI-rP11-4 expressed i
insoluble fractions. UN, uninduced control in which no lactose was added to the culture medi
time. Data expressed as (n ¼ 3)  95% conﬁdence limits. TEM analysis of E. coli cells carryin
and (E) uninduced showing no inclusion body formation.were washed in phosphate buffered saline (PBS). Each well was ﬁxed using 10% (v/v)
neutral buffered formalin for 10 min then stained with Giemsa solution (Merck R66
formulation) for 5 min. The wells were then repeatedly rinsed with distilled water
and the plate allowed to air dry at 25 C. The dry plates were examined by light
microscopy to view any changes in cell morphology and conﬂuence.
3. Results
3.1. Cloning and expression strategy
The cloning and expression strategy adopted for generating
the unimer P11-4 construct is shown in Fig. 2. The plasmid
pET31b-KSI-rP11-4(1)-HIS was previously generated [18]. This
plasmid contained a single P11-4 coding sequence, but has the C-
terminal Met and 6His tag which were not required in this study.
Site-directed mutagenesis was used to insert two translation
termination codons upstream of the C-terminal Met to prevent
expression of this Met or the 6His tag so that CNBr cleaved
product would result in release of a native sequence peptide from
the KSI partner. The correct sequence was conﬁrmed by DNA
sequencing and designated pET31b-KSI-rP11-4(1).
We then used this vector as a template for site-directed muta-
genesis to create a series of plasmids encoding other members of
the self-assembling peptide P11-family fused to the KSI gene in the
pET31b vector. The series of constructs generated encoded P11-2,
P11-4, P11-9, P11-13, P11-14, P11-20 and P11-4þRGD.
3.2. Expression of KSI-rP11-N from E. coli BL21 Star (DE3) by auto-
induction
The pET31b-KSI-rP11-N(1) plasmids were transformed into E.
coli BL21 Star (DE3) cells for expression trials. Initially cultures
expressing the KSI-P11-4 fusion protein were grown in 8ZY4Lacn E. coli BL21 (DE3) Star cells by auto-induction from 18 to 72 h in (A) soluble and (B)
um and grown for 72 h. (C) Changes in culture densities ( ) and protein yields ( ) over
g a pET31b-KSI-rP11-4 construct (D) induced showing dense inclusion body formation
Fig. 4. SDS-PAGE analysis of puriﬁcation of rP11-4 showing intact fusion protein KSI-
rP11-4 (A, lane 1) before CNBr cleavage, CNBr cleavage products showing the KSI
protein (C, lane 2), and puriﬁed rP11-4 using wash, ﬁltration and lyophilisation steps
(-, lane 3). The size (kDa) of molecular weight protein markers are indicated by M.
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samples taken at regular intervals. Soluble and insoluble cell frac-
tions were analysed by SDS-PAGE as shown in Fig. 3A and B. The
KSI-(P11-4) fusion protein was predominantly found in the insol-
uble fractions. The highest culture densities at OD600 of 18.8 were
reached after 70 h of growth (Fig. 3C). Insoluble protein yields were
determined to be at an optimum of 4.64 g/L when bacterial cells
were grown in 8ZY4Lac and harvested after 70 h growth. Auto-
induction expression cultures for the other pET31b-KSI-P11-N(1)
constructs in BL21 Star (DE3) were therefore subsequently grown
for 70 h before harvesting.
3.3. Visualisation of cytoplasmic inclusion bodies by TEM in E. coli
BL21 Star (DE3) cells expressing KSI-rP11-4
TEM was used to visualise electron dense inclusion bodies
within the cytoplasm of E. coli BL21 (DE3) Star cells after 48 h auto-
induction. TEM images showed electron dense areas at the poles of
the cells, which is typical of protein based inclusion bodies found in
the cytoplasm of E. coli cells (Fig. 3D). The negative control of E. coli
cells containing no plasmid showed heavy staining from uranyl
acetate yet no dense areas located at the poles of the cells were
observed (Fig. 3E).
3.4. Preparation of soluble and insoluble proteins from E. coli
cultures
Cells were lysed with lysis buffer 50 mM HEPES, 25% (w/v)
sucrose, 5 mM MgCl2.6H2O and 1% (v/v) Triton X-100. The pH of
the solution was adjusted to pH 8 using 6 M HCl or 6 M NaOH.
Immediately prior to use, Omnicleave endonuclease (2 ml per
40 ml lysis buffer; Epicentre, Cambridge, UK) was added to the lysis
buffer, together with lysozyme to 1 mg/ml. The lysate was soni-
cated on ice at 20 kHz using 4 bursts of 20 s on and 20 s off, then
centrifuged at 22,000 g for 30 min to separate the soluble and
insoluble material. Aliquots of the supernatant (soluble protein
fraction) were reserved for analysis. The pellet containing the
inclusion bodies was washed 4e5 times in 0.1 lysis buffer by
resuspension and centrifugation at 10,000 g. The resulting pellets
were stored at 20 C until required.
3.5. Cyanogen bromide cleavage of KSI-P11-4 and rP11-4
puriﬁcation
The process of cleavage and recovery of recombinant peptide
was initially optimised for rP11-4. CNBr was used to cleave the
inclusion body-based KSI fusion protein to release rP11-4. CNBr was
added to a 200-fold molar excess of methionine residues to protein
in 70% (v/v) formic acid in an oxygen free environment for 24 h, in
the dark. The cleaved mixture was resuspended in double distilled
water and the pH adjusted to 9 with ammonia. This should lead to
recovery of rP11-4 in an unimeric state in solution. The mixture was
centrifuged at 10,000 g for 30min.We investigated the potential for
puriﬁcation of rP11-4 from the supernatant without the use of
a chromatography step such as rpHPLC. The supernatant, at pH 9,
was passed through a 0.22 mm ﬁlter, lyophilised and resuspended in
10 ml double distilled water (pH 9) and agitated for 2 h so that the
peptide fully dissolved, then lyophilised. This process of resus-
pension at pH 9, ﬁltration and lyophilisation was repeated ﬁve
times and the resulting powder was resuspended in 2 ml double
distilled water (pH 9) and a sample electrophoresed together with
uncleaved and cleaved fusion protein, as shown in Fig. 4. It can be
clearly seen that an apparently pure peptide product was obtained
after these wash steps. It was essential to ensure that this simpleprotocol for producing pure peptide resulted in material that was
compatible with human cell growth which is addressed later.3.6. Cyanogen bromide cleavage of KSI-P11-N and rP11-N
puriﬁcation
The cleavage and peptide puriﬁcation procedure described
above for rP11-4 was subsequently applied to the inclusion body
pellets recovered from the cultures of the other KSI-P11-N samples.
Fig. 5A shows the results of an SDS-PAGE analysis of the uncleaved,
cleaved and puriﬁed peptide samples for the P11-2, P11-9, P11-13,
P11-14, and P11-4þRGD series. As observed for P11-4 (Fig. 4) it is
clear that CNBr cleavage has occurred and that apparently pure
peptide samples (Fig. 5A) were obtained after the series of wash,
ﬁltration and lyophilisation steps. This result indicates that the
production and simple non-chromatographic puriﬁcation strategy
is of general use for these self-assembling peptides.3.7. Mass spectrometry characterisation
To conﬁrm the identity of the fusion protein and puriﬁed rP11-4,
mass spectrometry was performed. The theoretical molecular mass
of KSI-P11-4 fusion protein determined using http://www.expasy.
ch/tools/protparam.html was 1,5140 Da and that obtained by
mass spectrometry was 1,5139.77 Da, which was in excellent
agreement. Mass spectrometry identiﬁed three main species
within the rP11-4 sample, the most abundant was 1537.7 Da with
þ17 Da species at 1553.6 Da and 1570.7 Da. Terminal glutamines
that are not chemically blocked are prone to cyclization to form
pyroglutamic acid with the loss of ammonia [23]. Given the theo-
retical molecular mass of rP11-4 at 1554.6 Da, the species at 1553.6
would correspond to rP11-4, perhaps as a deprotonated species.
Loss of ammonia from the N-terminal glutamine would give
a 1537.6 Da species consistent with the observed 1537.7 Da species.
It seemsmost likely that the 1570.7 species was due to an ammonia
adduct due to the use of ammonia to adjust the pH. MSMS analysis
conﬁrmed the identity of the peptide by identifying 8 of the 11
amino acids as N-.RFEWEFEQ.-C of rP11-4.
The other puriﬁed P11-N peptides were also characterised by
mass spectrometry and Fig. 5B provides the values for expected and
determined molecular masses for both the KSI fusion proteins and
for the puriﬁed peptides. The determined masses are in good
agreement with the expected values.
Fig. 5. (A). SDS-PAGE analysis of KSI-P11-N fusion proteins before CNBr cleavage (KSI-rP11-N (N is the peptide number)), post-CNBr cleavage (cleaved protein), and puriﬁed peptide
(rP11-N) recovered from the wash, ﬁltration and lyophilisation steps in water at pH 9. Arrows indicate the various protein/peptide species (6, KSI-rP11-N;B, KSI;,, rP11-N). M, low
molecular weight protein markers. (B) Sequence information, and theoretical and mass spectrometry determined mass data for the fusion proteins and puriﬁed peptides.
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acterisation and cytocompatibility studies as described in the
following sections.
3.8. rP11-4 peptide quantiﬁcation
UV spectrophotometry was used to quantify rP11-4 as we have
reported previously [18] by using the method proposed by [22] in
which the concentration (M) was determined from A280
(1 mg ml1; 1 cm) ¼ 5500/M, where 5500 is the molar extinction
coefﬁcient of rP11-4.
The KSI-P11-4 fusion protein has 137 amino acids and rP11-4
consisted of 11 amino acids, therefore rP11-4 comprises 8% of the
fusion protein. The maximum yield of fusion protein obtained by
auto-induction (8ZY4Lac) was 4.64 g/L, which theoretically equates
to 371.2 mg/L of rP11-4. Following cleavage with CNBr, the pHTable 2
Reported levels of production and yields of self-assembling peptides produced using rec
Peptide Host Fusion protein yield
(mg/L)
Theoretical p
yield (mg/L)
Ab11e26 Escherichia coli 80 27
RADA Ralstonia eutropha 433 116
SA2 Escherichia coli 300 30
P112 Escherichia coli 85 6.8
P112 Escherichia coli 330 32.1
P114 Escherichia coli 2500 530
P112 Pichia pastoris 800e1000 45
P1114 Pichia pastoris 600e700 75
P114 Escherichia coli 4640 371.2change, and several lyophilisation and wash steps in double
distilled water, the concentration of rP11-4 recovered equated to
203 mg/L which corresponds to a 55% yield. While further opti-
misation is required in relation to puriﬁcation efﬁciency, we have
achieved the highest levels of fusion protein and peptide recovery
so far reported in the literature without any chromatographic step
(Table 2).
3.9. Formation of a self-supporting rP11-4 peptide hydrogel in
physiological medium
As has been previously demonstrated [24] cP11-4 formed a self-
supporting hydrogel at a concentration of 10 mg/ml (6.4 mM) in cell
culture medium (DMEM) at pH 7.4. In this study, rP11-4 puriﬁed by
the lyophization and wash steps was resuspended in DMEM with
the addition of 140 mM NaCl to a ﬁnal concentration of 10 mg/ml.ombinant systems.
eptide Peptide puriﬁed
(mg/L)
Efﬁciency of peptide
puriﬁcation (%)
Reference
10 37 [27]
10.1 8.7 [28]
30 100 [29]
2.63 38.7 [17]
13 40.5 [20]
90 17 [18]
e e [30]
e e [30]
203 59.5 This study
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using HCl. At pH 7.4 a self-supporting hydrogel formed, whereas at
pH 9 no hydrogel formed and the sample remained in solution as
shown in Fig. 6A.3.10. Characterisation of rP11-4 ﬁbril formation
Aggeli and colleagues have shown that cP11-4 forms a self-
supporting hydrogel in 140 mM NaCl [24]. rP11-4 was diluted from
10 mg/ml in 140 mM NaCl and adjusted to 100 mM (0.156 mg/ml) at
pH 2 in double distilled water. The resulting ﬁbril morphologies can
be seen by TEM using uranyl acetate negative staining in Fig. 6B.
These images show that rP11-4 formed ﬁbrils similar to cP11-4
(Fig. 6C). The ﬁbrils were noted to be interconnecting with some
twists being evident. It was also evident that some of these ﬁbrils
were long and curly, as well as forming a mesh-like appearance,
whereas others were long and straight. Neighbouring ﬁbrils can be
seen as well as ﬁbriller bundles and entanglements. Rope-like
structures were also evident where individual ﬁbrils started to
elongate and wrap around each other.3.11. Characterisation of rP11-4 peptide secondary structure
We examined the secondary structure of rP11-4 using CD and
FTIR as a function of pH. Solutions of peptide were prepared at
a concentration of 10mg/ml in 140mM NaCl at pH 7.4 and pH 9, and
the samples were then diluted to 100 mM inwater with the pH being
reconﬁrmed. The CD spectra for rP11-4 at pH 7.4 and pH 9 are shown
in Fig. 7A and these spectral data correlate well with that obtained
for cP11-4 in Fig. 7B. An increase in pH lead to irregular structure
and random coil conformation with characteristic negative
minimum at ca. 200 nm and positive maximum at 218 nm. On
lowering the pH to 7.4, a conformational change occurred charac-
teristic of antiparallel b-sheet formationwith negative minimum at
218 nm and strong positive maximum at 198 nm.
FTIR analysis of rP11-4 further supported CD data showing that
at pH 7.4 a strong peak was observed at 1617 cm1 and aweak peak
at 1672 cm1 which conﬁrmed the antiparallel b-sheet conﬁgura-
tion of rP11-4. Upon increasing the pH to 9, a random coil conﬁg-
uration was adopted and conﬁrmed by the broad peak at
1642 cm1. The FTIR spectra of rP11-4 are shown in Fig. 7C and those
of cP11-4 which showed similar transitions in Fig. 7D.Fig. 6. (A) Formation of rP11-4 10 mg/ml self-supporting hydrogel in DMEM cell culture me
a pH shift to 9 resulted in peptide unimerisation and a geleliquid transition. The black arrow
stained samples of (B) rP11-4 and (C) cP11-4 revealed similar semi-rigid ﬁbril morphologies3.12. Cytocompatibility of rP11-4
rP11-4 samples were plated onto nutrient and heated blood agar,
and Sabouraud’s dextrose medium to check for potential microbial
growth. No growth of bacteria or fungi was observed on any of the
plates indicating that the ﬁltration protocol eliminated microbial
contaminants.
rP11-4 was prepared in DMEM plus supplements at a concen-
tration of 30mg/ml at pH 7.4. Contact cytotoxicity assays were used
to assess the cytocompatibility of rP11-4 with primary human
dermal ﬁbroblasts. This enabled preliminary assessment of any
toxicity proﬁle associated with rP11-4. It was found, by microscopic
examination, that primary human dermal ﬁbroblasts grew up to
and in contact with rP11-4 with no evidence of cytotoxicity
(Fig. 8AeB). There were no apparent changes in cellular
morphology nor were zones of cell lysis visible. This was compa-
rable to type I collagen (negative control), which also showed no
evidence of cytotoxicity (Fig. 8C). By contrast cyanoacrylate (posi-
tive control) caused cell lysis and agglomerated cell remnants were
seen (Fig. 8D).
4. Discussion
There are two broad strategies for the production of self-
assembling peptides: chemical synthesis and recombinant
production by transgenic organisms ranging from bacteria and
fungi to plants and animals. The use of microbial ‘biofactories’ for
protein synthesis is widely employed in industry owing to their
ease of use, robustness and low costs. Such recombinant systems
have the potential for large scale production of peptides and
proteins, although there are signiﬁcant challenges for the produc-
tion and efﬁcient puriﬁcation of short (10e30 amino acids) self-
assembling peptides.
The Gram-negative bacterium E. coli is an attractive system for
heterologous protein production due to its ability to grow rapidly to
high cell density on inexpensive substrates and excellent genetic
characterisation. The large scale production of insulin by Eli Lilly
(USA) and bovine growth hormone byMonsanto Corporation attest
to the versatility and economic potential of E. coli-based thera-
peutic protein production [25]. Recombinant protein expression
using E. coli as host is frequently associated with the formation of
intracellular protein aggregates as inclusion bodies. For most
protein production systems this is undesirable as recovery of
functional protein from inclusion bodies requires complexdium. A hydrogel formed under physiological conditions (pH 7.4, 140 mM NaCl) while
s indicate the position of the peptide sample. TEM analysis of uranyl acetate negative
with the presence of ﬁbrillar twists and bundles.
Fig. 7. Secondary structure analysis of rP11-4 and cP11-4. Circular dichroism analysis of (A) rP11-4 and (B) cP11-4 displayed as molar ellipticity showed similar transitions from b-sheet
to random coil upon pH switching from 7.4 ( ) to 9 ( ) respectively. FTIR spectra of (C) rP11-4 and (D) cP11-4 showing maxima at 1617 cm1 indicating b-sheet structure and weaker
maxima at 1672 and 1683 cm1 respectively, conﬁrming an antiparallel conformation. Broad maxima at 1642 cm1 are indicative of random coil for both rP11-4 and cP11-4.
Fig. 8. Contact cytotoxicity assay of rP11-4 at pH 7.4, 30 mg/ml in DMEM plus supplements following 48 h incubation with primary human dermal ﬁbroblasts. (AeB) rP11-4, (C)
collagen type I (negative control) and (D) cyanoacrylate (positive control). All images at 200 magniﬁcation, except B which is 400 magniﬁcation. White arrows indicate the
periphery of the material with which the cells grew in contact.
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issue and inclusion body recovery formed the basis of a method
involving tandem peptide repeats fused to KSI with a 6HIS tag for
puriﬁcation and intervening Met residues for CNBr cleavage [26].
This approach was used in a previous study [18] that demonstrated
the peptide coding sequence for P11-4 could be successfully
expressed as trimer tandem repeats in the pET31b expression
system as a KSI-P11-4(3)-6HIS construct, with fusion protein yields
of 2.5 g/L. Following CNBr cleavage, the recombinant P11-4 (rP11-4)
behaved similarly to the chemically synthesised counterpart, cP11-
4. The peptide yield obtained was the largest reported at that time
of 90 mg/L culture. However, the cleaved peptide product was
a combination of rP11-4, rP11-4-hsl and 6His tag peptide requiring
rpHPLC to resolve the former two species from the latter. The ﬁnal
rP11-4 sample remained amixture of peptide alone and that with an
additional homoserine lactone derived from the intervening Met
residue cleavage, resulting in a net charge change from 2 to 1 at
pH 7.4. This resulted in self-assembly occurring only at low pH, and
not at physiological pH necessary for cell culture and tissue engi-
neering applications.
The present study focussed on enhancing the production of rP11
peptides as unimer species, to overcome the unwanted generation
of homoserine lactone species, and on the development of a rapid
and simple non-chromatographic puriﬁcation strategy and ﬁnally
on the characterisation and cytocompatibility of one of the peptide
biomaterials, rP11-4.
Starting with a pET31b-KSI-P11-4(1)-HIS construct the existing
C-terminal 6HIS tag was removed from the expressed protein by
inserting two termination codons immediately after the P11-4
coding sequence by site-directed mutagenesis. Subsequent site-
directed mutagenesis of the resulting pET31b-KSI-P11-4(1) plasmid
allowed the generation of a series of P11-family peptide constructs.
In eliminating the afﬁnity tag for protein puriﬁcation, it was
essential that the method adopted for purifying the fusion protein
and peptide were simple and resulted in a pure peptide product.
Commonly rpHPLC, afﬁnity or exclusion chromatography methods
are used to obtain highly pure peptides and proteins, however,
resulting peptide yields are reduced and for scale-up applications
the costs associated with these puriﬁcation methods are high.
These considerations led us to develop a more cost-effective high
yield puriﬁcation strategy. E. coli cells were lysed by a detergent
lysis method and the insoluble, inclusion body fraction recovered
by centrifugation. This pellet which comprised predominantly the
KSI-rP11-4 fusion protein was treated with CNBr and cleavage was
at >90% efﬁcient. The sample was again centrifuged to recover the
supernatant whichwas adjusted to pH 9 then ﬁltered (0.22 mm) and
subjected to 5 cycles of lyophilisation and water wash steps. While
only ﬁve wash steps were performed it seems likely that further
wash steps may increase the purity of the resulting peptide. SDS-
PAGE analysis conﬁrmed that the resulting rP11-4 showed no
contamination with fusion protein.
Likewise the same simple cleavage, wash, ﬁltration and lyo-
philisation strategy was shown to be suitable for puriﬁcation of
P11-2, P11-9, P11-13, P11-14, P11-20 and P11-4þRGD demonstrating
the generic nature of this approach for these short self-assembling
peptides that display divergent amino acid sequences.
From a theoretical rP11-4 peptide yield of 371.2 mg/L, a 55%
recovery was achieved of 203 mg/L culture. This exceeds our
previous demonstration of 90 mg/L and we believe this now to be
the highest reported self-assembling peptide yield to be recovered
from a recombinant system, notable as our puriﬁcation strategy
does not involve a chromatographic step. This certainly represents
one of the simplest recovery methods reported yet with the
highest yield of target peptide. Losses may have occurred in the
ﬁltration step, where some self-assembly may have occurred dueto a concentration effect and further optimisation of this approach
may achieve even higher yields.
Middelberg and co-workers also recently reported a chroma-
tography-free puriﬁcation system in which homogenized cell
pellets were heat treated to 55 C for 15min. TEV proteasewas then
added to release the P11-2 peptide from the thioredoxin fusion
partner. The cleavage reaction was then precipitated by ethanol
(75% v/v) in the presence of 250 mM NaCl, centrifuged and the
supernatant dried before the peptide was resuspended in water.
The overall yield was 40% allowing recovery of 13 mg/L culture,
although the culture density was signiﬁcantly lower than we ach-
ieve by auto-induction. An rpHPLC polishing step was still used for
buffer exchange of the peptide sample prior to self-assembly
analysis [20] whereas in our study we used the peptide directly
from the wash and lyophilisation process.
The capacity of rP11-4 to form a self-supporting hydrogel was
assessed. rP11-4 was prepared at the same concentration
(10 mg ml1) in cell culture medium (DMEM) at pH 7.4 and it
started to form a viscous liquid within minutes. After equilibration
for 24 h at 25 C, it had formed a self-supporting hydrogel. To assess
whether rP11-4 behaved in a similar pH-responsivemanner to cP11-
4, the pH of rP11-4 was increased to pH 9 and a liquid state formed
instantaneously conﬁrming that rP11-4 behaved in a similar pH-
responsive manner to cP11-4 becoming unimeric at pH 9.
TEM showed that rP11-4 formed ﬁbrils with lengths and widths
similar to those reported for cP11-4 reported by [13,18,24] and to our
previouslypuriﬁedrP11-4/rP11-4 (hsl) [18]. Circulardichroismanalysis
suggested that the predominant secondary structure of rP11-4 at
physiological pH (pH 7.4) was antiparallel b-sheet, as has been
observed for rP11-4/rP11-4 (hsl) [18] and for cP11-4 [13]. Upon
adjusting to pH 9, a conformational transition to random coil
occurred. FTIR analysis also indicated an antiparallel b-sheet confor-
mation at pH 7.4 and a random coil conformation at pH 9. These data
indicated that rP11-4 behaves similarly to cP11-4 [13] and [24].
Cytocompatibility studies were performed, in which primary
human dermal ﬁbroblasts were grown up to and in contact with
rP11-4, collagen I and cyanoacrylate for 48 h. This indicated that
rP11-4 puriﬁed by ﬁltration, lyophilisation and wash steps alone
was compatible with growth of these primary human cells.
5. Conclusions
We have demonstrated that various P11-family b-structure self-
assemblingpeptides canbeproduced inanE. coliexpression system .
Efﬁcient puriﬁcation was achieved by CNBr cleavage and a series of
simplewash,ﬁltration and lyophilisation steps. For rP11-4whichwas
analysed in greatest detail, this ultimately resulted in a peptide yield
of 203 mg/L which we believe to be the highest reported self-
assembling peptide yield to date. Microscopic and spectroscopic
analysis showed that rP11-4 had essentially identical properties to
the chemically synthesised counterpart (cP11-4). rP11-4 self-assem-
bled into a hydrogel in physiological conditions and cytocompati-
bility studies indicated that rP11-4 hydrogel was non-cytotoxic
towards primary human dermal ﬁbroblasts. This study demon-
strates that rP11-4 and other P11-series peptides can be produced in
a sustainable manner using an E. coli expression system resulting in
a pure peptide without the need for costly chromatographic puriﬁ-
cation strategies. This method has great potential for large scale
production of self-assembling peptides as scaffolds for tissue engi-
neering and human cell culture studies are underway.
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